One of the most fascinating aspects of genome editing is its ability to potentially enhance not just human health but human capabilities. Take, for example, the controversial experiments in China where scientists edited genes in embryos to make babies resistant to certain diseases and possibly even smarter or fitter. These advancements spark ethical debates, but they also show the immense potential of genome editing to change the course of human evolution. If we can edit genes to fight diseases, enhance physical traits, and even improve intelligence, the possibilities seem endless.
But it’s not just about humans. Genome editing could also revolutionize agriculture. Imagine editing crops to be more resilient to climate change, grow faster, or be more nutritious. This could help feed the world’s growing population more efficiently and sustainably, with less reliance on harmful pesticides and fertilizers.
Or grow more meat by editing genes of animal.
Looking ahead, the potential applications of genome editing expand even further. If humanity is serious about colonizing Mars, we’ll need people who can withstand the harsh conditions of space and the Red Planet. Genetic editing could play a role in enhancing human abilities to survive in those extreme environments, from boosting resistance to radiation to adapting to lower gravity.
Also super soldiers like Captain America would be used in defence.
Investing in companies like CRSP, NTLA, and BEAM might be one way to tap into this growing sector.
Since Crispr already was approved by fda (casgevy) in 2023